Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants

Clinical trial NCT00325156 · COMPLETED

Trial details

NCT number: NCT00325156
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diphtheria Tetanus Poliomyelitis Acellular Pertussis Haemophilus Influenzae Type b Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines

Start date: 2004-11-02
Primary completion: 2007-08-23
Enrollment: 2590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.